Dr. Anna Gaddy, M.D

NPI: 1619326980
Total Payments
$16,014
2024 Payments
$15,864
Companies
8
Transactions
17
Medicare Patients
651
Medicare Billing
$90,042

Payment Breakdown by Category

Consulting$14,302 (89.3%)
Food & Beverage$874.30 (5.5%)
Travel$837.89 (5.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $14,302 2 89.3%
Food and Beverage $874.30 10 5.5%
Travel and Lodging $837.89 5 5.2%

Top Paying Companies

Company Total Records Latest Year
Otsuka Pharmaceutical Development & Commercialization, Inc. $12,123 3 $0 (2024)
CALLIDITAS THERAPEUTICS US INC. $2,250 1 $0 (2024)
Otsuka America Pharmaceutical, Inc. $953.72 7 $0 (2024)
Travere Therapeutics, Inc. $281.46 2 $0 (2024)
Mallinckrodt Hospital Products Inc. $131.38 1 $0 (2024)
Alexion Pharmaceuticals, Inc. $124.99 1 $0 (2024)
Merck Sharp & Dohme Corporation $76.92 1 $0 (2018)
GlaxoSmithKline, LLC. $72.91 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $15,864 15 Otsuka Pharmaceutical Development & Commercialization, Inc. ($12,123)
2022 $72.91 1 GlaxoSmithKline, LLC. ($72.91)
2018 $76.92 1 Merck Sharp & Dohme Corporation ($76.92)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/06/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $119.83 General
10/23/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $161.63 General
10/08/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. TOLVAPTAN (Drug) Food and Beverage Cash or cash equivalent $36.81 General
Category: NEPHROLOGY
10/08/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. TOLVAPTAN (Drug) Travel and Lodging Cash or cash equivalent $34.00 General
Category: NEPHROLOGY
10/03/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. TOLVAPTAN (Drug) Consulting Fee Cash or cash equivalent $12,052.00 General
Category: NEPHROLOGY
09/06/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Consulting Fee Cash or cash equivalent $2,250.00 General
Category: Nephrology
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Travel and Lodging In-kind items and services $303.97 General
Category: NEPHROLOGY
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $52.60 General
Category: NEPHROLOGY
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $43.78 General
Category: NEPHROLOGY
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Travel and Lodging In-kind items and services $38.99 General
Category: NEPHROLOGY
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Travel and Lodging In-kind items and services $30.48 General
Category: NEPHROLOGY
08/25/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Travel and Lodging In-kind items and services $430.45 General
Category: NEPHROLOGY
08/25/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $53.45 General
Category: NEPHROLOGY
06/17/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $124.99 General
06/13/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $131.38 General
Category: CRITICAL CARE
05/12/2022 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $72.91 General
Category: IMMUNOLOGY
09/11/2018 Merck Sharp & Dohme Corporation STEGLATRO (Drug) Food and Beverage In-kind items and services $76.92 General
Category: ENDOCRINOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 283 458 $287,062 $37,737
2022 12 275 374 $391,569 $39,302
2021 6 93 128 $119,975 $13,003
Total Patients
651
Total Services
960
Medicare Billing
$90,042
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 53 104 $50,752 $9,275 18.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 59 62 $48,236 $7,962 16.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 51 77 $42,581 $7,794 18.3%
90935 Hemodialysis procedure with physician evaluation Facility 2023 57 113 $91,756 $6,086 6.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 28 46 $15,410 $2,737 17.8%
90945 Dialysis procedure including 1 evaluation Facility 2023 12 33 $27,687 $1,980 7.2%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 11 11 $6,380 $1,096 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 12 12 $4,260 $806.52 18.9%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 14 35 $157,045 $9,571 6.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 49 83 $39,342 $6,378 16.2%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 12 20 $72,360 $4,495 6.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 24 24 $18,120 $3,566 19.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 36 45 $15,525 $3,202 20.6%
90935 Hemodialysis procedure with physician evaluation Facility 2022 33 45 $35,460 $2,457 6.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 21 21 $11,823 $2,031 17.2%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 14 14 $10,080 $1,925 19.1%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 23 24 $11,040 $1,787 16.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 11 13 $6,981 $1,329 19.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 23 27 $6,318 $1,322 20.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 15 23 $7,475 $1,241 16.6%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 14 18 $63,234 $4,124 6.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 24 45 $20,700 $3,534 17.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 15 15 $10,995 $2,282 20.8%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 14 20 $15,300 $1,120 7.3%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 13 14 $4,690 $1,068 22.8%

About Dr. Anna Gaddy, M.D

Dr. Anna Gaddy, M.D is a Nephrology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1619326980.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Gaddy, M.D has received a total of $16,014 in payments from pharmaceutical and medical device companies, with $15,864 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($14,302).

As a Medicare-enrolled provider, Gaddy has provided services to 651 Medicare beneficiaries, totaling 960 services with total Medicare billing of $90,042. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Milwaukee, WI
  • Active Since 06/08/2016
  • Last Updated 06/21/2021
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1619326980

Products in Payments

  • TOLVAPTAN (Drug) $12,123
  • TARPEYO (Drug) $2,250
  • JYNARQUE (Drug) $953.72
  • TERLIVAZ (Drug) $131.38
  • STEGLATRO (Drug) $76.92
  • BENLYSTA (Biological) $72.91

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Milwaukee